<DOC>
	<DOCNO>NCT00472355</DOCNO>
	<brief_summary>The purpose study determine low dos apomorphine worsen motor symptom Parkinson 's disease .</brief_summary>
	<brief_title>Low Dose Apomorphine Parkinsonism</brief_title>
	<detailed_description>The goal study learn people Parkinson 's disease ( PD ) get bad right take PD medication carbidopa/levodopa medication wear . In study scientist determine apomorphine , drug use treat symptom PD , worsen motor symptom people PD low dos drug give continuous subcutaneous infusion . A continuous subcutaneous infusion mean drug administer continuously small needle place skin . Apomorphine , PD drug work similar carbidopa/levodopa , use study faster-acting brief effect carbidopa/levodopa . After initial screening , participant enter 3-day treatment phase receive random order low dose apomorphine , high dose apomorphine , placebo ( inactive substance ) . All participant receive study drug 2 day 2 different dos ( low high ) placebo 1 day . During 3 day participant provide blood sample heart monitor . Parkinsonism monitor day speed finger tapping , foot tap walk well tremor dyskinesia score . Duration study participant approximately 4 5 day include 1-2 outpatient visit 3-day inpatient hospital stay .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Apomorphine</mesh_term>
	<criteria>Have idiopathic Parkinson 's disease treat levodopa experience motor fluctuation Response levodopa document 10 percent increase finger foot tap speed Clinically significant cardiovascular , cerebrovascular , hepatic renal disease Psychosis Allergy apomorphine 5ht3 inhibitor Prolonged qt interval Pregnancy/breastfeeding Hemodynamic instability Severe nausea Alcohol/drug abuse Other unstable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>PD</keyword>
	<keyword>apomorphine</keyword>
</DOC>